Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 8-K Event Regulation FD disclosure
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations · Other events
  8. 4 Open-market sale Chief Technical Officer sold 21,493 shares at an average $26.89 ($578,038)
  9. 4/A Derivatives Options or other derivatives
  10. 4 Open-market sale Chief Scientific Officer sold 4,250 shares at an average $19.20 ($81,592)
  11. 3/A Insider 3/A
  12. SC 13D/A Stake Beneficial Ownership Report
  13. DEFA14A Proxy Proxy Materials
  14. DEF 14A Proxy Proxy Statement
  15. 4 Open-market sale Chief Scientific Officer sold 4,250 shares at an average $21.36 ($90,763)
  16. 4 Option exercise Chief Financial Officer acquired 400 shares (option exercise)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. SC 13G Stake Amended Statement of Ownership
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 38 of 47 · 923 filings